Solid organ transplantation (SOT) is a life-saving procedure for treatment for patients with end-stage organ failure. While SOT can be a boon for critically ill patients, it can also lead to post-transplant diabetes mellitus (PTDM). For instance, PTDM develops in 10–20% of patients with kidney transplants and in 20–40% of patients who have undergone any other SOT. This article highlights potential factors responsible for PTDM and also focusses on the possible strategies by which PTDM can be best managed.
PTDM is mostly studied in recipients of kidney transplants, but patients with heart, liver, and lung transplants are also at risk of PTDM. It has been reported that 10–40% of patients undergoing SOT suffer from PDTM during their first year of transplantation. Factors responsible for predisposition of patients to PTDM Diagnosis of PTDM Based on an international consensus report…
